in Its Intellectual Property on AlivaMab Mouse and Immunoglobulin Locus Engineering
in Its Intellectual Property on AlivaMab Mouse and Immunoglobulin Locus Engineering
in Its Intellectual Property on AlivaMab Mouse and Immunoglobulin Locus Engineering
MORE
Next
1
2
3
About
For efficient discovery and development of antibody and antibody-derivative drug candidates.
Our license options are designed to meet the needs of our partners.
Ablexis Announces Progress in Its Intellectual Property on AlivaMab Mouse and Immunoglobulin Locus Engineering
10581 Roselle Street, Suite 115
San Diego, CA 92121